» Articles » PMID: 35694871

Lp-PLA2 As a Biomarker and Its possible Associations with SARS-CoV-2 Infection

Overview
Journal Biomark Med
Date 2022 Jun 13
PMID 35694871
Authors
Affiliations
Soon will be listed here.
Abstract

Lp-PLA2 is an enzyme encoded by the gene located at chromosome 6p12-21, which is included in different signal transduction pathways. The potential of serum levels of Lp-PLA2 as a marker of inflammation quantifying cardio-metabolic risk, renal impairment and oxidative stress has been explored in earlier studies. It has also been used in chronic obstructive pulmonary disease, hepatic disease, metabolic conditions and exercise tolerance. Additionally, it shows promising evidence for the assessment of risk for certain cardiovascular conditions in otherwise seemingly healthy individuals. COVID-19 has affected life and the economy globally. The identification of biomarkers to assess the sickness and treatment plan is the need of the hour. This review summarizes the pathophysiological inter-relationship between serum levels of Lp-PLA2 and COVID-19. The authors hypothesize that the estimation of Lp-PLA2 levels may help in the early identification of risk and thus may play a beneficial role in the proactive management of COVID-19.

Citing Articles

Organ-Dysfunction Markers in Mild-to-Moderate COVID-19 Convalescents.

Wisniewska A, Kijak A, Nowak K, Lulek M, Skwarek A, Malecka-Gieldowska M J Clin Med. 2024; 13(8).

PMID: 38673514 PMC: 11050795. DOI: 10.3390/jcm13082241.


Comparison of Different Vascular Biomarkers for Predicting In-Hospital Mortality in Severe SARS-CoV-2 Infection.

Suto R, Pocsi M, Fagyas M, Kalina E, Fejes Z, Szentkereszty Z Microorganisms. 2024; 12(1).

PMID: 38276214 PMC: 10820061. DOI: 10.3390/microorganisms12010229.


Screening of Lipid Metabolism-Related Genes as Diagnostic Indicators in Chronic Obstructive Pulmonary Disease.

Jiang C, Peng M, Dai Z, Chen Q Int J Chron Obstruct Pulmon Dis. 2023; 18:2739-2754.

PMID: 38046983 PMC: 10693249. DOI: 10.2147/COPD.S428984.


The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study.

English C, Lohning A, Mayr H, Jones M, MacLaughlin H, Reidlinger D Nutr Metab (Lond). 2023; 20(1):38.

PMID: 37700354 PMC: 10496320. DOI: 10.1186/s12986-023-00756-x.


Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A in Ischemic Stroke.

Zhang S, Huang S, Hu D, Jiang F, Lv Y, Liu G Cardiovasc Ther. 2022; 2022:3328574.

PMID: 36313479 PMC: 9586817. DOI: 10.1155/2022/3328574.

References
1.
Liu Z, Li H, Zheng Y, Gao Z, Cong L, Yang L . Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study. Sci Rep. 2018; 8(1):10127. PMC: 6031645. DOI: 10.1038/s41598-018-28494-8. View

2.
Byrne C, Targher G . NAFLD: a multisystem disease. J Hepatol. 2015; 62(1 Suppl):S47-64. DOI: 10.1016/j.jhep.2014.12.012. View

3.
Zalewski A, Macphee C . Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol. 2005; 25(5):923-31. DOI: 10.1161/01.ATV.0000160551.21962.a7. View

4.
Favas T, Dev P, Chaurasia R, Chakravarty K, Mishra R, Joshi D . Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020; 41(12):3437-3470. PMC: 7577367. DOI: 10.1007/s10072-020-04801-y. View

5.
Diaz-Pollan B, Estrada V, Fuentes-Ferrer M, Gomez-Garre D, Roman-Montero J . Lp-PLA2 levels in HIV-infected patients. J Int AIDS Soc. 2014; 17(4 Suppl 3):19721. PMC: 4225389. DOI: 10.7448/IAS.17.4.19721. View